Both in Lab Analytical Instruments
Pacific Biosciences of California vs 908 Devices
Over the past year PACB returned +46.4% and MASS returned +45.4%; their daily moves had a correlation of 0.45.
PACB +46.4% MASS +45.4%Growth of $1, one year, split-adjusted
| Metric | PACB | MASS |
|---|---|---|
| Price | $1.83 | $11.85 |
| Market cap | $568.8M | $489.8M |
| Today | +7.02% | +1.63% |
| 1 month | +30.7% | +10.4% |
| 6 months | +45.2% | +106.1% |
| Year to date | −2.1% | +125.7% |
| 1 year | +51.2% | +47.9% |
| Revenue growth (YoY) | −1.9% | +23.3% |
| Gross margin | 32.4% | 51.9% |
| Net margin | −114.7% | −74.0% |
| P/E (TTM) | — | — |
| Price / sales | 3.6× | 8.1× |
| Net cash | -$407.5M | $101.5M |
| Dividend yield | — | — |
| Volatility (60d) | 83.2% | 58.4% |
| Short % of float | 19.6% | 9.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).